No Data
No Data
Bausch + Lomb to Return EnVista Intraocular Lenses to Market After Voluntary Recall
Bausch + Lomb To Resume EnVista IOL Distribution After Identifying Cause Behind Voluntary Recall
Bausch + Lomb's ONE By ONE And Biotrue Eye Care Recycling Programs Collect Over 100M Units Of Used Materials
Barclays Names Most and Least Affected Healthcare Companies From Tariffs
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
RBC Capital Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Cuts Target Price to $17
Benjamin’s : New CEO